mAbSolution IVS: Financial statements 2016
CVR: 36893729
mAbSolution IVS (CVR 36893729) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -7,600 and a net result of DKK -7,612. Equity amounted to DKK -9,862.
- Gross Profit
- -7,600 kr.
- Profit/Loss
- -7,612 kr.
- Equity
- -9,862 kr.
- Total Assets
- 2,388 kr.
How creditworthy is mAbSolution IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
As of December 7, 2016, Lars Nørgaard has stepped down as director of mAbSolution IVS.
MAbSolution IVS has published its interim report for the period May 13, 2015 – December 31, 2015.
About mAbSolution IVS
mAbSolution IVS was a Danish company of the type Iværksætterselskab based in Kgs. Lyngby, founded in 2015 and dissolved in 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2017, the company reported a gross profit of DKK -13,668 and a net result of DKK -13,668 compared with DKK -7,612 the year before. Equity amounted to DKK -33,920.
